# The Effects of Losartan on Reward Reinforcement Learning

> **NCT04604938** · NA · UNKNOWN · sponsor: **University of Electronic Science and Technology of China** · enrollment: 60 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Losartan
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04604938
- **Lead sponsor:** University of Electronic Science and Technology of China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-10
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04604938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04604938, "The Effects of Losartan on Reward Reinforcement Learning". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04604938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*